Botox And Myobloc Should Carry Stricter Warnings Consumer Group Petitions FDA

Citing deaths linked to the use of the drugs, Public Citizen, an American consumer advocacy group has petitioned the US Food and Drug Administration (FDA) to increase its warnings and directly advise patients and doctors about the dangers of botulinum toxin, available commercially as Botox and Myobloc.

More: continued here

Filed under: Cosmetic Medicine on January 29th, 2008